Growing concern about the emergence of monkeypox in Europe and the U.S. has sent shares of several vaccine and drug companies soaring. Though infections are rarely reported outside of Central and West...
Growing concern about the emergence of monkeypox in Europe and the U.S. has sent shares of several vaccine and drug companies soaring. Though infections are rarely reported outside of Central and West...